Acuta Capital Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-55,000
| Closed | -$1.3M | – | 49 |
|
|
2019
Q3 | $1.3M | Buy |
+55,000
| New | +$1.3M | 0.94% | 22 |
|
|
2018
Q2 | – | Sell |
-270,000
| Closed | -$1.43M | – | 73 |
|
|
2018
Q1 | $1.43M | Buy |
+270,000
| New | +$1.43M | 0.23% | 26 |
|
|
2017
Q4 | – | Sell |
-71,500
| Closed | -$1.04M | – | 74 |
|
|
2017
Q3 | $1.04M | Sell |
71,500
-302,007
| -81% | -$4.41M | 0.19% | 31 |
|
|
2017
Q2 | $7M | Buy |
373,507
+125,551
| +51% | +$2.35M | 1.96% | 12 |
|
|
2017
Q1 | $5.28M | Sell |
247,956
-129,953
| -34% | -$2.77M | 1.25% | 18 |
|
|
2016
Q4 | $5.74M | Buy |
+377,909
| New | +$5.74M | 2.13% | 17 |
|